Země: Singapur
Jazyk: angličtina
Zdroj: HSA (Health Sciences Authority)
DOCETAXEL, TRIHYDRATE
SANOFI-AVENTIS SINGAPORE PTE. LTD.
L01CD02
80mg/2ml
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Prescription Only
Aventis Pharma, Dagenham (Concentrate: bulk, filling, packing & labelling)
2008-03-19
TAXOTERE 80 MG docetaxel The following information is intended for medical or healthcare professionals only: PREPARATION GUIDE FOR USE WITH TAXOTERE 80 MG CONCENTRATE FOR SOLUTION FOR INFUSION AND SOLVENT FOR TAXOTERE IT IS IMPORTANT THAT YOU READ THE ENTIRE CONTENTS OF THIS PROCEDURE PRIOR TO THE PREPARATION OF EITHER THE TAXOTERE PREMIX SOLUTION OR THE TAXOTERE INFUSION SOLUTION. 1. FORMULATION TAXOTERE 80 mg concentrate for solution for infusion is a clear viscous, yellow to brownish-yellow solution containing 40 mg/ml docetaxel (anhydrous) in polysorbate 80. The solvent for TAXOTERE is a 13% w/w solution of ethanol 95% in water for injections. 2. PRESENTATION TAXOTERE is supplied as single-dose vials. Each box contains one TAXOTERE vial (80 mg) and one corresponding solvent for TAXOTERE vial in a blister pack. TAXOTERE vials should be stored between 2 and 25°C and protected from light. TAXOTERE should not be used after the expiry date shown on the carton, blister pack and vials. 2.1 TAXOTERE 80 MG VIAL • The TAXOTERE 80 mg vial is a 15 ml clear glass vial with a red flip-off cap. • The TAXOTERE 80 mg vial contains a solution of docetaxel in polysorbate 80 at a concentration of 40 mg/ml. • Each TAXOTERE 80 mg vial contains 2.0 ml of a 40 mg/ml solution of docetaxel in polysorbate 80 (fill volume: 94.4 mg/2.36 ml). This volume has been established during the development of TAXOTERE to compensate for liquid loss during preparation of the premix (see section 4) due to foaming, adhesion to the walls of the vial and “dead-volume”. This overfill ensures that after dilution with the entire contents of the accompanying solvent for TAXOTERE vial, there is a minimal extractable premix volume of 8 ml containing 10 mg/ml docetaxe Přečtěte si celý dokument